EEF2K and esophageal squamous cell carcinoma: Furthermore, YY1BM is involved in the progression of ESCC by inhibiting the interaction between YY1 and the androgen receptor (AR), leading to a decrease in the expression of eukaryotic elongation factor-2 kinase (eEF2K) through the AR signaling pathway.